| Racial/ethnic disparities in genomic sequencing DE Spratt, T Chan, L Waldron, C Speers, FY Feng, OO Ogunwobi, ... JAMA oncology 2 (8), 1070-1074, 2016 | 286 | 2016 |
| Associations of luminal and basal subtyping of prostate cancer with prognosis and response to androgen deprivation therapy SG Zhao, SL Chang, N Erho, M Yu, J Lehrer, M Alshalalfa, C Speers, ... JAMA oncology 3 (12), 1663-1672, 2017 | 264 | 2017 |
| Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis SG Zhao, SL Chang, DE Spratt, N Erho, M Yu, HAD Ashab, M Alshalalfa, ... The lancet oncology 17 (11), 1612-1620, 2016 | 212 | 2016 |
| The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression YS Niknafs, S Han, T Ma, C Speers, C Zhang, K Wilder-Romans, MK Iyer, ... Nature communications 7 (1), 12791, 2016 | 208 | 2016 |
| Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells L Chen, JA Mayer, TI Krisko, CW Speers, T Wang, SG Hilsenbeck, ... Cancer research 69 (23), 8853-8861, 2009 | 172 | 2009 |
| The immune landscape of prostate cancer and nomination of PD-L2 as a potential therapeutic target SG Zhao, J Lehrer, SL Chang, R Das, N Erho, Y Liu, M Sjöström, RB Den, ... JNCI: Journal of the National Cancer Institute 111 (3), 301-310, 2019 | 163 | 2019 |
| Development and validation of a novel radiosensitivity signature in human breast cancer C Speers, S Zhao, M Liu, H Bartelink, LJ Pierce, FY Feng Clinical Cancer Research 21 (16), 3667-3677, 2015 | 149 | 2015 |
| Estrogen receptor mutations and their role in breast cancer progression PG Alluri, C Speers, AM Chinnaiyan Breast Cancer Research 16, 1-8, 2014 | 130 | 2014 |
| Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment S Kregel, C Wang, X Han, L Xiao, E Fernandez-Salas, P Bawa, ... Neoplasia 22 (2), 111-119, 2020 | 123 | 2020 |
| Identification of novel kinase targets for the treatment of estrogen receptor–negative breast cancer C Speers, A Tsimelzon, K Sexton, AM Herrick, C Gutierrez, A Culhane, ... Clinical cancer research 15 (20), 6327-6340, 2009 | 117 | 2009 |
| Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer AM Gonzalez-Angulo, BT Hennessy, F Meric-Bernstam, A Sahin, W Liu, ... Clinical proteomics 8, 1-15, 2011 | 115 | 2011 |
| Maternal embryonic leucine zipper kinase (MELK) as a novel mediator and biomarker of radioresistance in human breast cancer C Speers, SG Zhao, V Kothari, A Santola, M Liu, K Wilder-Romans, ... Clinical Cancer Research 22 (23), 5864-5875, 2016 | 108 | 2016 |
| Glioblastoma therapy can be augmented by targeting IDH1-mediated NADPH biosynthesis DR Wahl, J Dresser, K Wilder-Romans, JD Parsels, SG Zhao, M Davis, ... Cancer research 77 (4), 960-970, 2017 | 105 | 2017 |
| Postoperative radiotherapy after breast-conserving surgery for early-stage breast cancer: a review C Speers, LJ Pierce JAMA oncology 2 (8), 1075-1082, 2016 | 105 | 2016 |
| Effect of epidermal growth factor receptor inhibitor on development of estrogen receptor–negative mammary tumors C Lu, C Speers, Y Zhang, X Xu, J Hill, E Steinbis, J Celestino, Q Shen, ... Journal of the National Cancer Institute 95 (24), 1825-1833, 2003 | 103 | 2003 |
| Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a de novo low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer DE Spratt, M Alshalalfa, N Fishbane, AB Weiner, R Mehra, BA Mahal, ... Clinical Cancer Research 25 (22), 6721-6730, 2019 | 85 | 2019 |
| ARe we there yet? Understanding androgen receptor signaling in breast cancer AR Michmerhuizen, DE Spratt, LJ Pierce, CW Speers NPJ breast cancer 6 (1), 47, 2020 | 78 | 2020 |
| Clinicogenomic radiotherapy classifier predicting the need for intensified locoregional treatment after breast-conserving surgery for early-stage breast cancer M Sjöström, SL Chang, N Fishbane, E Davicioni, SG Zhao, L Hartman, ... Journal of Clinical Oncology 37 (35), 3340, 2019 | 72 | 2019 |
| Recent time trends and predictors of heart dose from breast radiation therapy in a large quality consortium of radiation oncology practices LJ Pierce, M Feng, KA Griffith, R Jagsi, T Boike, D Dryden, GS Gustafson, ... International Journal of Radiation Oncology* Biology* Physics 99 (5), 1154-1161, 2017 | 70 | 2017 |
| Concurrent veliparib with chest wall and nodal radiotherapy in patients with inflammatory or locoregionally recurrent breast cancer: the TBCRC 024 phase I multicenter study R Jagsi, KA Griffith, JR Bellon, WA Woodward, JK Horton, A Ho, FY Feng, ... Journal of Clinical Oncology 36 (13), 1317, 2018 | 68 | 2018 |
